Postprandial effects of the phosphodiesterase-5 (PDE-5) inhibitor tadalafil in type 2 diabetes patients: a randomised controlled trial

被引：0
作者：
Sjogren, L.
Olausson, J.
Strindberg, L.
Mobini, R.
Fogelstrand, P.
Hulten, L. Mattsson
Jansson, P. -A.
机构：
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
116
引用
收藏
页码：S55 / S56
页数：2
相关论文
共 50 条
[31]   Phosphodiesterase-5 (PDE-5) is up-regulated in cirrhotic rat livers; Potential role for PDE-5 inhibitors in reducing the increased intrahepatic vascular tone in cirrhosis [J].
Loureiro-Silva, M ;
Iwakiri, Y ;
Abraldes, JG ;
Haq, O ;
Groszmann, RJ .
HEPATOLOGY, 2004, 40 (04) :271A-271A
[32]   EFFECTS OF PHOSPHODIESTERASE TYPE 5 INHIBITOR, TADALAFIL, ON CONTINENCE REFLEX IN RATS [J].
Hideaki, I ;
Kaiho, Y. ;
Eriguchi, T. ;
Kamiyama, Y. ;
Kawamorita, N. ;
Yamashita, S. ;
Nakagawa, H. ;
Arai, Y. .
NEUROUROLOGY AND URODYNAMICS, 2015, 34 :S100-S100
[33]   Effects of phosphodiesterase type 5 inhibitor, tadalafil, on continence reflex in rats [J].
Izumi, Hideaki ;
Kaiho, Yasuhiro ;
Miyazato, Minoru ;
Kawamorita, Naoki ;
Nakagawa, Haruo ;
Arai, Yoichi .
INTERNATIONAL UROGYNECOLOGY JOURNAL, 2014, 25 (12) :1721-1727
[34]   Effects of phosphodiesterase type 5 inhibitor, tadalafil, on continence reflex in rats [J].
Hideaki Izumi ;
Yasuhiro Kaiho ;
Minoru Miyazato ;
Naoki Kawamorita ;
Haruo Nakagawa ;
Yoichi Arai .
International Urogynecology Journal, 2014, 25 :1721-1727
[35]   The long acting phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size [J].
Sesti, C ;
Florio, V ;
Kloner, RA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) :170A-170A
[36]   Positive effect of tadalafil, a phosphodiesterase-5 inhibitor, on fracture healing in rat femur [J].
Togral, Guray ;
Arikan, S. Murat ;
Korkusuz, Petek ;
Hesar, Ramin Hashemi ;
Eksioglu, M. Fatih .
EKLEM HASTALIKLARI VE CERRAHISI-JOINT DISEASES AND RELATED SURGERY, 2015, 26 (03) :137-144
[37]   ASSESSMENT OF HEADACHE IN MEN TAKING PHOSPHODIESTERASE-5 INHIBITOR (TADALAFIL) FOR ERECTILE DYSFUNCTION [J].
Okuyucu, E. Esra ;
Guven, Oguz ;
Ucar, Edip ;
Duman, Taskin .
ACTA MEDICA MEDITERRANEA, 2014, 30 (05) :1007-1011
[38]   Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries [J].
Wareing, M ;
Myers, JE ;
O'Hara, M ;
Kenny, LC ;
Warren, AY ;
Taggart, MJ ;
Skillern, L ;
Machin, I ;
Baker, PN .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (05) :1283-1290
[39]   Treatment of Raynaud's phenomena with the PDE-5 inhibitor, Cialis (tadalafil) in patients with scleroderma and lupus. [J].
Baak, SW .
ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :S169-S169
[40]   Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3′,5′ guanosine monophosphate (cGMP) level in podocytes [J].
Fang, Lilla ;
Radovits, Tamas ;
Szabo, Gabor ;
Mozes, Miklos M. ;
Rosivall, Laszlo ;
Koekeny, Gabor .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (07) :1751-1761
12345